Studies on effects of dietary fatty acids as related to their position on triglycerides.
This article reviews published literature on how the stereospecific structure of dietary triglycerides may affect lipid metabolism in humans. Animal studies have shown enhanced absorption of fatty acids in the sn-2 position of dietary triglycerides. Increasing the level of the saturated fatty acid palmitic acid in the sn-2 position (e.g., by interesterification of the fat to randomize the positions of the fatty acids along the glycerol backbone) has been shown in rabbits to increase the atherogenic potential of the fat without impacting levels of blood lipids and lipoproteins. In contrast, enhancing the level of stearic acid in the sn-2 position has not been found to affect either atherogenic potential or levels of blood lipids and lipoproteins in rabbits. Fatty acids other than palmitic and stearic have not been studied systematically with respect to possible positional effects. A limited number of human studies have shown no significant effects of interesterified fats on blood lipid parameters. However, it is unknown whether modifying the stereospecific structure of dietary triglycerides would affect atherogenicity or other long-term health conditions in humans. It is possible that incorporation of palmitic acid into the sn-2 position of milk fat is beneficial to the human infant (as a source of energy for growth and development) but not to human adults. Additional research is needed to determine whether processes like interesterification, which can be used to alter physical parameters of dietary fats (e.g., melting characteristics), may result in favorable or unfavorable long-term effects in humans.
Hunter
J E
JE
Department of Chemistry, University of Cincinnati, Ohio 45221-0172, USA. hunterje@email.uc.edu
D000042:Absorption; D000818:Animals; D001161:Arteriosclerosis / Q000209:etiology; D004041:Dietary Fats / Q000032:analysis / Q000493:pharmacokinetics / Q000494:pharmacology*; D004951:Esterification; D005227:Fatty Acids / Q000737:chemistry* / Q000494:pharmacology*; D006801:Humans; D008055:Lipids / Q000097:blood; D008074:Lipoproteins / Q000097:blood; D013329:Structure-Activity Relationship; D014280:Triglycerides / Q000737:chemistry* / Q000494:pharmacology*
D004041:Dietary Fats; D005227:Fatty Acids; D008055:Lipids; D008074:Lipoproteins; D014280:Triglycerides